In March 2025, the company introduced new designs to get a direct-to-purchaser supplying of its Wegovy weight loss drug. The company proven a fresh pharmacy, termed NovoCare, which would charge clients $499 every month for use of the drug, lower than half the cost of the drug by way of other pharmaceutical distribution networks.[53]Novo Nordisk A/S